Document Detail

Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.
MedLine Citation:
PMID:  22270809     Owner:  NLM     Status:  MEDLINE    
Advances in the understanding of the endogenous cannabinoid system have led to several therapeutic indications for new classes of compounds that enhance cannabinergic responses. Endocannabinoid levels are elevated during pathogenic conditions, and inhibitors of endocannabinoid inactivation promote such on-demand responses. The endocannabinoids anandamide and 2-arachidonoyl glycerol have been implicated in protective signaling against excitotoxic episodes, including seizures. To better understand modulatory pathways that can exploit such responses, we used the new generation compound AM6701 that blocks both the anandamide-deactivating enzyme fatty acid amide hydrolase (FAAH) and the 2-arachidonoyl glycerol-deactivating enzyme monoacylglycerol lipase (MAGL) with equal potency. Also studied was the structural isomer AM6702 which is 44-fold more potent for inhibiting FAAH versus MAGL. When applied before and during kainic acid (KA) exposure to cultured hippocampal slices, AM6701 protected against the resulting excitotoxic events of calpain-mediated cytoskeletal damage, loss of presynaptic and postsynaptic proteins, and pyknotic changes in neurons. The equipotent inhibitor was more effective than its close relative AM6702 at protecting against the neurodegenerative cascade assessed in the slice model. In vivo, AM6701 was also the more effective compound for reducing the severity of KA-induced seizures and protecting against behavioral deficits linked to seizure damage. Corresponding with the behavioral improvements, cytoskeletal and synaptic protection was elicited by AM6701, as found in the KA-treated hippocampal slice model. It is proposed that the influence of AM6701 on FAAH and MAGL exerts a synergistic action on the endocannabinoid system, thereby promoting the protective nature of cannabinergic signaling to offset excitotoxic brain injury.
Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Related Documents :
12375939 - A novel synthesis of n-methyl asparagine, arginine, histidine, and tryptophan.
8612049 - A new procedure for the labeling of peptides and amino acids.
3985309 - A carbene-yielding amino acid for incorporation into peptide photoaffinity reagents.
1820059 - Serine proteinase-catalyzed incorporation of d-amino into model peptides in acetonitril...
21757409 - D-amino acid metabolism in mammals: biosynthesis, degradation and analytical aspects of...
5500319 - The effect of hypermethylation on the functional properties of transfer ribonucleic aci...
7806149 - The role of sodium in the uptake of ursodeoxycholic acid in isolated hamster hepatocytes.
1229719 - The phenolics of fruits. vii. the phenolics of cherries and plums and the changes in ca...
23220819 - Nitrogen removal of ramie stalk treated by acid wastewater combined with clostridium th...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics     Volume:  9     ISSN:  1878-7479     ISO Abbreviation:  Neurotherapeutics     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-25     Completed Date:  2013-06-19     Revised Date:  2013-10-14    
Medline Journal Info:
Nlm Unique ID:  101290381     Medline TA:  Neurotherapeutics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  801-13     Citation Subset:  IM    
Biotechnology Research and Training Center, William C. Friday Laboratory, University of North Carolina Pembroke, Pembroke, North Carolina 28372, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amidohydrolases / antagonists & inhibitors*
Convulsants / toxicity
Endocannabinoids / metabolism*
Enzyme Inhibitors / pharmacology
Hippocampus / drug effects,  enzymology
Monoacylglycerol Lipases / antagonists & inhibitors*
Neurons / drug effects,  enzymology*
Organ Culture Techniques
Rats, Sprague-Dawley
Seizures / enzymology*
Tetrazoles / toxicity
Grant Support
Reg. No./Substance:
0/AM 6701; 0/Convulsants; 0/Endocannabinoids; 0/Enzyme Inhibitors; 0/Tetrazoles; EC Lipases; EC 3.5.-/Amidohydrolases; EC 3.5.1.-/fatty-acid amide hydrolase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Iron phthalocyanine coated on single-walled carbon nanotubes composite for the oxygen reduction reac...
Next Document:  Pharmacological and nonpharmacological management of delirium in critically ill patients.